CTRI/2013/12/004194招募中未知
TO EVALUATE THE SAFETY OF METFORMIN IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 3 a and b
Dr Manish Rathi0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with Type 2 diabetes mellitus and CKD stage 3a and 3b whose blood sugar is not controlled with oral hypoglycemic agents other than metformin with or without insulin.
排除标准
- •1)Patients with CKD stage 4 & 5
- •2)Acute kidney injury
- •3) Congestive cardiac failure
- •4)Liver failure
- •5)Alcohol abuse
- •6)Hypoxemia
- •7)Refusal to give consent
研究者
相似试验
已完成
不适用
The effect of metformin in diabetic patients with kidney diseaseKidney diseaseType 2 diabetesRenal and Urogenital - Kidney diseaseMetabolic and Endocrine - DiabetesACTRN12611000893909Prof Richard Day7
已完成
4 期
The safety and disposition of metformin in people with liver diseaseChronic liver diseaseMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12619001292167St Vincent's Hospital, Sydney24
已完成
不适用
The safety and disposition of metformin in people with liver disease and diabetes already treated with metformiChronic liver diseaseMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonDiabetesACTRN12619001348145St Vincent's Hospital, Sydney34
招募中
3 期
Evaluation of the Protective Effect of Metformin against the Tamoxifen Induced Changes on Endometrium and OvariesIRCT20140820018866N9Tehran University of Medical Sciences100
尚未招募
2 期
Metformin in the prevention of preeclampsiaPre-eclampsiapreeclampsia.IRCT20230730058975N1Esfahan University of Medical Sciences160